(Q39718987)

14 September 2017

0 references

Eculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysis (English)

1 reference

14 September 2017

0 references

Jon Jin Kim

1

1 reference

14 September 2017

Simon C Waller

series ordinal

2

1 reference

14 September 2017

Christopher J Reid

series ordinal

3

1 reference

14 September 2017

30 January 2012

1 reference

Clinical kidney journal / an academic journal of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association)

14 September 2017

1 reference

14 September 2017

5

1 reference

14 September 2017

1

1 reference

14 September 2017

34-36

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

14 September 2017

start time

2 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Successful Isolated Liver Transplantation in a Child with Atypical Hemolytic Uremic Syndrome and a Mutation in Complement Factor H

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

aHUS caused by complement dysregulation: new therapies on the horizon

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Complement inhibitor eculizumab in atypical hemolytic uremic syndrome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Eculizumab for congenital atypical hemolytic-uremic syndrome.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4400463

Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26069744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NDTPLUS/SFR174

1 reference

release_ra73a5yw7veafbpal5jb36o6sa

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ra73a5yw7veafbpal5jb36o6sa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 September 2017

PubMed publication ID

26069744

1 reference